Cargando…

Pancreatic cancer genomics: insights and opportunities for clinical translation

Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor les...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makohon-Moore, Alvin, Brosnan, Jacqueline A, Iacobuzio-Donahue, Christine A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064313/ https://www.ncbi.nlm.nih.gov/pubmed/23673020 http://dx.doi.org/10.1186/gm430

Ejemplares similares

An unusual genomic variant of pancreatic ductal adenocarcinoma with an indolent clinical course
por: Kohutek, Zachary A., et al.
Publicado: (2017)

Characterization of genetic subclonal evolution in pancreatic cancer mouse models
por: Niknafs, Noushin, et al.
Publicado: (2019)

Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer
por: Zhang, Haochen, et al.
Publicado: (2023)

Reconstructing metastatic seeding patterns of human cancers
por: Reiter, Johannes G., et al.
Publicado: (2017)

Tumor diversity and evolution revealed through RADseq
por: Perry, Elizabeth B., et al.
Publicado: (2017)

Retrotransposon insertions in the clonal evolution of pancreatic ductal adenocarcinoma
por: Rodić, Nemanja, et al.
Publicado: (2015)

Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma
por: Vakiani, Efsevia, et al.
Publicado: (2017)

Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic
por: Du, Yongxing, et al.
Publicado: (2017)

Cross-platform Comparison of Two Pancreatic Cancer Phenotypes
por: Scharpf, Robert B., et al.
Publicado: (2010)

Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
por: Łuksza, Marta, et al.
Publicado: (2022)

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
por: Askan, Gokce, et al.
Publicado: (2021)

Translating genomic medicine to the clinic: challenges and opportunities
por: Zhang, Huan, et al.
Publicado: (2019)

Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility
por: Dhara, S., et al.
Publicado: (2021)

Host genetics and infectious disease: new tools, insights and translational opportunities
por: Kwok, Andrew J., et al.
Publicado: (2020)

Nanotechnology in reproductive medicine: Opportunities for clinical translation
por: Shandilya, Ruchita, et al.
Publicado: (2020)

3D genome organization in health and disease: emerging opportunities in cancer translational medicine
por: Babu, Deepak, et al.
Publicado: (2015)

Core Steps of Membrane-Bound Peptidoglycan Biosynthesis: Recent Advances, Insight and Opportunities
por: Teo, Alvin C. K., et al.
Publicado: (2015)

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice
por: Dong, Anliang, et al.
Publicado: (2016)

The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation
por: de Mel, Sanjay, et al.
Publicado: (2018)

Opportunities and challenges in translational science
por: Austin, Christopher P.
Publicado: (2021)

Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma
por: Hayashi, Akimasa, et al.
Publicado: (2020)

Advanced pancreatic cancer: The standard of care and new opportunities
por: Mohammad, Amrallah A.
Publicado: (2018)

Artificial intelligence in clinical and translational science: Successes, challenges and opportunities
por: Bernstam, Elmer V., et al.
Publicado: (2021)

Functional roles of SRC signaling in pancreatic cancer: Recent insights provide novel therapeutic opportunities
por: Poh, Ashleigh R., et al.
Publicado: (2023)

Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment
por: Lu, Shuangshuang, et al.
Publicado: (2017)

In Vivo Cell Tracking Using PET: Opportunities and Challenges for Clinical Translation in Oncology
por: Lechermann, Laura M., et al.
Publicado: (2021)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Barriers and opportunities for gemcitabine in pancreatic cancer therapy
por: Beutel, Alica K., et al.
Publicado: (2023)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

The patterns and dynamics of genomic instability in metastatic pancreatic cancer
por: Campbell, Peter J, et al.
Publicado: (2010)

Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges
por: Qian, Fuliang, et al.
Publicado: (2018)

Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer
por: Garrido-Laguna, I, et al.
Publicado: (2010)

Widespread somatic L1 retrotransposition occurs early during gastrointestinal cancer evolution
por: Ewing, Adam D., et al.
Publicado: (2015)

Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer
por: Romeo, Margarita, et al.
Publicado: (2018)

Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma
por: Bijlsma, Maarten F., et al.
Publicado: (2022)

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
por: Haque, Muhammad R., et al.
Publicado: (2021)

Current epidemiology of pancreatic cancer: Challenges and opportunities
por: Luo, Wenhao, et al.
Publicado: (2020)

Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response
por: Gross, Annette S., et al.
Publicado: (2022)

The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities
por: Masugi, Yohei
Publicado: (2022)

Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights
por: Biello, Federica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_or5p9fprr5e0kug4qmqb4er656